Neurophos secures funding round to advance photonic AI chip. Neurophos is a semiconductor startup based in Austin, that manufactures high powered, energy efficient photonic chips for AI inference. The company was established by Dr Patrick Bowen and Dr Andrew Traverso, who have gathered a professional team of experts with deep experience from major tech and hardware companies such NVDIA, Apple and Meta. Neurophos just secured a funding round from major investors including M12(Microsoft) to advance its photonic AI chip development. The company is addressing a major bottleneck in the AI industry. Traditional silicon based GPUs are struggling to support the demands of modern AI algorithms. To solve this Neurophos has developed a novel Optical Processing Unit (OPU). Unlike traditional chips, this chip uses light-based(photonic) computing and metamaterials to perform calculations. The company has been able to achieve massive miniaturization, they have managed to shrink optical components by 10000x, allowing them to fit over a million processing elements onto a single chip. The company has claimed that the chips have huge performance gains, their technology can provide up to 100x the performance and energy efficiency of traditional chips. Neurophos also claims that their chips are more sustainable, reducing the amount of electricity required for high level AI inference, hence reducing the carbon footprint of data centers. Neurophos also chips also boasts seamless integration, the chips are designed to be drop in replacements for existing GPUs, allowing data centers to easily upgrade their infrastructure. The new capital will be used to finalize the company's first integrated compute system, expand its software stack and open a new engineering facility in San Francisco. Investors and industry experts view this as a "physics-level" breakthrough that would be able to support modern AI models, as traditional Moore's law begins to plateau.

Aramco & Gates Frontier lead USD 110M round in us-based Neurophos. * US-based Neurophos raised USD 110M in a Series A led by Gates Frontier, with participation from M12 and Aramco Ventures. * Founded in 2020, the startup is developing photonic AI inference chips aimed at cutting power consumption and easing data center energy constraints. * The funding will support launching its first photonic compute system and expanding operations from Austin to a new San Francisco site. Neurophos. US-based Neurophos, a photonic AI chip technology startup, raised USD 110 million in a Series A funding round. The round was led by Gates Frontier, with participation from M12 (Microsoft's Venture Fund) and Aramco Ventures. It also saw participation from Carbon Direct Capital, Bosch Ventures, Tectonic Ventures, Space Capital, and others. Founded in 2020 by Dr. Patrick Bowen and Dr. Andrew Traverso, Neurophos is an AI chip startup. It is focusing on developing high-performance, energy-efficient photonic AI inference chips. Its technology aims to enable significant reductions in power consumption. With this, it seeks to support the next generation of AI infrastructure without exponential increases in energy or physical resources. Moreover, it aims to facilitate making AI more accessible and cost-effective across industries. "Neurophos is addressing the only problem that really matters for the future of AI: the limits imposed by silicon. Their optical architecture provides the foundation for the next generation of machine intelligence," said Chris Alliegro, Managing Partner at MetaVC Partners. AI chip. Looking forward, with the new funding, it aims to accelerate the delivery of its first integrated photonic compute system. This includes datacenter-ready OPU modules, a full software stack, and early-access developer hardware. It also seeks to support its expansion from its Austin, Texas headquarters and open a San Francisco engineering site to meet early customer demand. "This physics-level shift means both efficiency and raw speed improve as we scale up, breaking free from the power walls that constrain traditional GPUs," said Dr. Patrick Bowen, CEO and Co-Founder of Neurophos.